Cargando…
Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran
BACKGROUND: Surfactant dysfunction due to inhibition is involved in the pathophysiology of meconium aspiration syndrome. Dextran addition has been shown to reverse exogenous surfactant inactivation by meconium, but the precise mechanisms and the morphological correlate of this effect are yet unknown...
Autores principales: | Ochs, Matthias, Schüttler, Markus, Stichtenoth, Guido, Herting, Egbert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489943/ https://www.ncbi.nlm.nih.gov/pubmed/16756655 http://dx.doi.org/10.1186/1465-9921-7-86 |
Ejemplares similares
-
In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant.
por: Park, K. H., et al.
Publicado: (1996) -
Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro
por: Stichtenoth, Guido, et al.
Publicado: (2013) -
Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits
por: Stichtenoth, Guido, et al.
Publicado: (2017) -
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023) -
Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome
por: Kopincova, Jana, et al.
Publicado: (2019)